These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38527263)

  • 1. Local and Systemic Management Options for Melanoma Brain Metastases.
    Amouzegar A; Tawbi HA
    Cancer J; 2024 Mar-Apr 01; 30(2):102-107. PubMed ID: 38527263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Treatment of Melanoma Brain Metastasis.
    Rishi A; Yu HM
    Curr Treat Options Oncol; 2020 Apr; 21(6):45. PubMed ID: 32350685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.
    Ahmed KA; Abuodeh YA; Echevarria MI; Arrington JA; Stallworth DG; Hogue C; Naghavi AO; Kim S; Kim Y; Patel BG; Sarangkasiri S; Johnstone PA; Sahebjam S; Khushalani NI; Forsyth PA; Harrison LB; Yu M; Etame AB; Caudell JJ
    Ann Oncol; 2016 Dec; 27(12):2288-2294. PubMed ID: 27637745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging options for patients with melanoma brain metastases.
    Kreidieh FY; Tawbi HA
    Clin Adv Hematol Oncol; 2022 Oct; 20(10):619-627. PubMed ID: 36206074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    Kotecha R; Miller JA; Venur VA; Mohammadi AM; Chao ST; Suh JH; Barnett GH; Murphy ES; Funchain P; Yu JS; Vogelbaum MA; Angelov L; Ahluwalia MS
    J Neurosurg; 2018 Jul; 129(1):50-59. PubMed ID: 28799876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the systemic treatment of melanoma brain metastases.
    Glitza Oliva IC; Schvartsman G; Tawbi H
    Ann Oncol; 2018 Jul; 29(7):1509-1520. PubMed ID: 29790899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma Brain Metastasis: Biology and Therapeutic Advances.
    Hasanov M; Acikgoz Y; Davies MA
    Hematol Oncol Clin North Am; 2024 Oct; 38(5):1027-1043. PubMed ID: 38845301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Melanoma CNS Metastases.
    Jang S; Atkins MB
    Cancer Treat Res; 2016; 167():263-79. PubMed ID: 26601867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma brain metastases: an unmet challenge in the era of active therapy.
    Gorantla V; Kirkwood JM; Tawbi HA
    Curr Oncol Rep; 2013 Oct; 15(5):483-91. PubMed ID: 23954973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review.
    Goyal S; Silk AW; Tian S; Mehnert J; Danish S; Ranjan S; Kaufman HL
    JAMA Oncol; 2015 Aug; 1(5):668-76. PubMed ID: 26181286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of systemic therapy in melanoma brain metastases: a narrative review.
    Saleem K; Davar D
    Chin Clin Oncol; 2022 Jun; 11(3):24. PubMed ID: 35818856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Treatment of Melanoma Brain Metastases.
    Kibbi N; Kluger H
    Curr Oncol Rep; 2016 Dec; 18(12):73. PubMed ID: 27822695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Era in the Management of Melanoma Brain Metastases.
    Tawbi HA; Boutros C; Kok D; Robert C; McArthur G
    Am Soc Clin Oncol Educ Book; 2018 May; 38():741-750. PubMed ID: 30231345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsurgical Management of Melanoma Brain Metastasis: Current Therapeutics, Challenges, and Strategies for Progress.
    Makawita S; Tawbi HA
    Am Soc Clin Oncol Educ Book; 2021 Mar; 41():79-90. PubMed ID: 34010041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in therapy for brain metastases in melanoma patients.
    Wilkes JG; Patel A; McClure E; Pina Y; Zager JS
    Expert Opin Pharmacother; 2021 Aug; 22(11):1443-1453. PubMed ID: 33688795
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases.
    Dohm AE; Nakashima JY; Kalagotla H; Jiang SX; Tang JD; Bhandari M; Kim Y; Graham JA; Khushalani NI; Forsyth PA; Etame AB; Liu JK; Tran ND; Vogelbaum MA; Wuthrick EJ; Yu HM; Oliver DE; Ahmed KA
    Eur J Cancer; 2023 Oct; 192():113287. PubMed ID: 37657227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy-A retrospective cohort study.
    Gatterbauer B; Hirschmann D; Eberherr N; Untersteiner H; Cho A; Shaltout A; Göbl P; Fitschek F; Dorfer C; Wolfsberger S; Kasprian G; Höller C; Frischer JM
    Cancer Med; 2020 Jun; 9(11):4026-4036. PubMed ID: 32249551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort.
    Tétu P; Allayous C; Oriano B; Dalle S; Mortier L; Leccia MT; Guillot B; Dalac S; Dutriaux C; Lacour JP; Saiag P; Brunet-Possenti F; De Quatrebarbes J; Stoebner PE; Legoupil D; Beylot-Barry M; Lesimple T; Aubin F; Dreno B; Mohamed S; Ballon A; Porcher R; Lebbe C
    Eur J Cancer; 2019 May; 112():38-46. PubMed ID: 30909072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma brain metastases - Interdisciplinary management recommendations 2020.
    Gutzmer R; Vordermark D; Hassel JC; Krex D; Wendl C; Schadendorf D; Sickmann T; Rieken S; Pukrop T; Höller C; Eigentler TK; Meier F
    Cancer Treat Rev; 2020 Sep; 89():102083. PubMed ID: 32736188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
    Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS
    Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.